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S2 
General Information and Methods 
 
Chemicals and Reagents 
All chemicals, reagents, media, organic solvents, resins for chromatography and other materials 
used in this study were obtained from Sigma-Aldrich Co Limited, Fisher Scientific UK Limited, 
Agilent Technologies UK Limited, Roche Applied Sciences, and VWR International Limited. The 
Escherichia coli expression cells BL21 (DE3) and C41 (DE3) strains were obtained from Promega 
UK and Cambridge Bioscience Limited; respectively. Gene sequencing and oligonucleotide 
synthesis were performed by Eurofins MWG (Ebersberg, Germany). The expression vectors 
pET21b and pET15b were from Novagen. The substrates (-)-menthone, (+)-dihydrocarvone and 
(+)-pulegone used in this study were commercially available, and were dissolved in absolute 
ethanol (0.25 M or 0.5 M). The normal lactones of (-)-menthone, (+)-dihydrocarvone of (+)-
pulegone were synthesised by NewChem Technologies Limited to be used as authentic standards 
for qualitative and quantitative analyses only. The anhydrous organic solvents were of extra dry 
grade and were stored and opened under strict anaerobic conditions in a glove box. 
Mg(BHT)2(THF)2 was synthesised as previously reported,
1, 2
 kindly donated by Dr John Morrison, 
School of Chemistry, University of Manchester and stored in a glove box until used. 
Oligonucleotide primer sequences 
Site-directed mutagenesis of wild-type (WT) CHMOPhi1 was performed using the QuikChange 
lightning site-directed mutagenesis kit (Agilent) according to the manufacturer’s protocols. The 
sequence of the primer pairs for mutation introduction by PCR can be found in Table S1. 
 
Table S1. Primer sequences for the construction of the CHMOPhi1 F249A/F280A/F435A triple mutant (variant 
CHMOPhi1). 
Mutation Direction Sequence 
F249A Forward 
Reverse 
5’-GTGAAAAAAAGCGCAGTTGCCGCGGGTTTTGAAGAAAGCACCCTG-3’ 
5’-CAGGGTGCTTTCTTCAAAACCCGCGGCAACTGCGCTTTTTTTCAC-3’ 
F280A Forward 
Reverse 
5’-GCATGGGATCATGGTGGTGGCGCGCGTTTTATGTTTGGCACC-3’ 
5’-GGTGCCAAACATAAAACGCGCGCCACCACCATGATCCCATGC -3’ 
F435A Forward 
Reverse 
5’-GGGTCCGAATGGTCCGGCGACCAATCTGCCTCCGAG-3’ 
5’-CTCGGAGGCAGATTGGTCGCCGGACCATTCGGACCC-3’ 
The mutated bases are underlined 
Protein production and analysis 
Cultures of E. coli containing BVMOs/CRE-BVMOs were grown in 2xYT medium (500 mL; 
tryptone 16 g/L, yeast extract 10 g/L and 5 g/L NaCl pH 7.0), containing ampicillin (100 mg/mL) 
and a 1% inoculum of an overnight pre-culture in the same medium.  Cultures were incubated at 
37°C until OD600nm reached 0.6, followed by an 18 h induction with isopropyl-β-D-1-
thiogalactopyranoside (IPTG; 10 µM for CHMOPhi1, and  CRE-CHMO Phi1; 500 µM for CPDMO; 
100 µM for CRE-CPDMO) at 24 C. Cells were harvested by centrifugation at 5000g for 10 min at 
4°C. Cell-free extracts (CFE) for biotransformations were generated by resuspending the cell pellet 
in PBS buffer (10 mM pH 7.4) containing phenylmethylsufonylfluoride and lysing by 
ultrasonication (4 C). The extracts were clarified by centrifugation at 26600g, diluted to a protein 
 
 
S3 
concentration of 15 mg/mL, stored at -20 C in 1 mL aliquots and either used directly or stored at -
20 C.  
Protein expressions were assessed by SDS-PAGE, using 12% Mini-PROTEAN TGX Stain-Free 
gels and the Precision Plus protein unstained markers (BioRad; Figure S1). Protein concentrations 
were measured by Bradford method using the Bio-Rad protein assay kit according to 
manufacturer’s instructions. Table S2 shows a representative example of purified protein yields, 
which varied from batch to batch. 
 
 
Figure S1. SDS-PAGE analysis of the BVMOs showing the protein expression levels in cell pellets/lysates. A) 
CPDMO from Pseudomonas sp. HI-70, lane 1: protein marker, lane 2: CFE of CRE-CPDMO, lane 3: cell pellet of 
CRE-CPDMO, lane 4: cell lysate of CPDMO, B) The WT CHMO from Rhodococcus sp. Phi1 (CHMOPhi1) and its 
F299A/F330A/F485A variant of, lane 1: protein marker, lanes 2, 3 CFE of WT CHMOPhi1, lane 4: CFE of the variant of 
CHMOPhi1. C) CRE-WT CHMOPhi1, lane 1: protein marker, lanes 2-7 CFEs from various batches. D) CRE-CHMOPhi1 
variant, lane1: protein marker, lanes 2-4 CFEs from various batches. 
 
Table S2. Total protein concentrations of the produced BVMOs in cell pellets. 
Enzyme Protein Yield 
(mg/g cell pellet) 
CPDMO 60.2 
CRE-CPDMO 70.0 
Wild type (WT) CHMOPhi1 59.2 
WT CRE-CHMOPhi1 86.0 
CHMOPhi1 variant  54.6 
CRE-CHMOPhi1 variant  69.0 
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Figure S2. UV-Visible spectra of the purified BVMOs.  A) CPDMO from Pseudomonas sp. HI-70 (20 µM), B) WT 
CHMOPhi1 (16 µM) and C) The variant of CHMOPhi1 (63 µM). Spectra were obtained in 50 mM Tris buffer, pH 7.0 at 25 
C. 
 
Gas Chromatography/Mass Spectroscopy (GC/MS) Analysis  
Biotransformation extracts were analysed on an Agilent Technologies 7890B GC system with a 
5977A MSD extractor EI source detector using a DB-WAX column (30 m x 0.32 mm x 0.25 M 
film thickness; Agilent Technologies). In this method the injector temperature was set at 240°C 
with a split ratio of 20:1 (1 L injection). The carrier gas was helium with a flow rate of 2 mL/min 
and a pressure of 4.6 psi. The program began at 50 °C (1 min hold), ramped to 230 °C at 8°C/min, 
with a hold at 230 °C (1 min). The ion source temperature of the mass spectrometer (MS) was set to 
230°C and spectra were recorded from m/z 50 to m/z 250. The mass spectra fragmentation patterns 
were entered into the NIST/EPA/NIH 11 mass spectral library for identification of a potential 
match. Compound identification was carried out using authentic standards and also by comparison 
to reference spectra in the NIST library of MS spectra and fragmentation patterns. Quantitative 
analysis using authentic standards was performed using experimentally determined relative 
response factors in relation to the internal standard used (0.1% sec-butyl-benzene).  
 
NMR Spectroscopy 
NMR analyses were performed on a Bruker 400 MHz NMR spectrometer. 
1
H NMR and 
13
C NMR 
spectra were recorded in deuterated chloroform (CDCl3) and the chemical shifts were referenced to 
internal tetramethylsilane (TMS). 
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GC/MS Chromatograms and Data Analysis 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. GC/MS chromatograms of A) (-)-menthone and B) menthide compound standards. Each compound (5 
mM) was dissolved in ethyl acetate containing 0.1% sec-butyl-benzene. The retention times (5.1 min for sec-butyl-
benzene here and throughout) and mass fragmentation pattern for each compound are shown in the upper and lower 
panels of each part, respectively.  
A 
B 
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Figure S4. GC/MS chromatograms of the biotransformation reaction product of the purified CPDMO with (-)-
menthone. Biotransformation reaction conditions: purified CPDMO (2 M), (-)-menthone (5 mM), NADP+ (15 M), 
glucose (15 mM), glucose dehydrogenase (GDH from Pseudomonas sp., 10U) in 1 mL 50 mM Tris buffer, pH 7.0 at 28 
C. The reaction products were extracted in ethyl acetate containing 0.1% sec-butyl-benzene as internal standard for 
GC/MS analysis. The retention times and mass fragmentation pattern for each compound are shown in the upper and 
lower panels, respectively. 
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Figure S5. GC/MS chromatograms of the biotransformation reaction products of CFE of CPDMO (A) and CFE 
of CRE-CPDMO (B) with (-)-menthone. Reaction conditions: A) CFE of CPDMO (50 L), (-)-menthone (5 mM), 
NADP
+
 (15 M), glucose (15 mM) and glucose dehydrogenase (GDH from Pseudomonas sp., 10U) in 1 mL 50 mM 
Tris buffer, pH 7.0 at 28 C. B) CFE of CRE-CPDMO (50 L), (-)-menthone (5 mM) and 100 mM sodium phosphite in 
1 mL 50 mM Tris buffer, pH 7.0 at 28 C The reaction products were extracted in ethyl acetate containing 0.1% sec-
butyl-benzene as internal standards for GC/MS analysis. The retention times and mass fragmentation pattern for each 
compound are shown in the upper and lower panels of each part, respectively. Additional tiny peaks at RT of 15.432 
was also identified. 
A 
B 
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Figure S6. GC/MS chromatograms of the biotransformation reaction products of the CFE of CRE-CPDMO with 
5 mM (-)-menthone in a 500 mL reaction volume. Reaction conditions: CFE of CRE-CPDMO (50 L/mL), (-)-
menthone (5 mM) and  100 mM sodium phosphite in 500 mL 50 mM Tris buffer, pH 7.0 at 28 C. The reaction 
products were extracted in ethyl acetate containing 0.1% sec-butyl-benzene as internal standards for GC/MS analysis. 
The retention times and mass fragmentation pattern for each compound are shown in the upper and lower panels, 
respectively. The retention times for (-)-menthone, menthide product and a possible additional lactone isomer are 8.416, 
15.253 and 15.432, respectively. Additional tiny peaks at RT of 8.86 was also identified. 
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Figure S7. GC/MS chromatograms of the biotransformation reaction products of the CFE of CRE-CPDMO with 
10 mM (-)-menthone in 500 mL reaction volume. Biotransformation reaction conditions: CFE of CRE-CPDMO (50 
L/mL), (-)-menthone (10 mM) and 100 mM sodium phosphite in 500 mL 50 mM Tris, pH 7.0 at 28 C. The reaction 
products were extracted in ethyl acetate containing 0.1% sec-butyl-benzene as internal standards for GC/MS analysis. 
The retention times and mass fragmentation pattern for each compound are shown in the upper and lower panels, 
respectively. The retention times for (-)-menthone, menthide product and isomenthone are 8.447, 15.264 and 8.86, 
respectively. Additional tiny peaks at RT of 8.86 was also identified. 
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Figure S8. GC/MS chromatograms of the (+)-dihydrocarvone and dihydrocarvide (the normal lactone of 
(2R,5R)-(+)-dihydrocarvone) standards. A) Spectrum of (+)-dihydrocarvone (5 mM) which is a mixture of 77% of 
the  (2R,5R) isomer (RT = 10.585 min) and 22% of the (2R,5S) isomer (RT = 10.845 min). Both isomers have identical 
mass spectra as shown in red. B) Spectrum of the normal lactone (5 mM) in green (RT = 17.422). Both standards were 
prepared in ethyl acetate containing 0.1 % sec-butyl-benzene as internal standard for GC/MS analysis.  
 
 
A 
B 
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Figure S9. GC/MS chromatograms of the reaction products of purified WT CHMOPhi1 A) and variant CHMOPhi1 
B) with (+)-dihydrocarvone. Biotransformation reaction conditions: WT CHMOPhi1 or its variant (2 M), (+)-
dihydrocarvone (5 mM), NADP
+
 (15 M), glucose (15 mM), glucose dehydrogenase (GDH from Pseudomonas sp., 
10U) in 1 mL 50 mM Tris buffer, pH 7.0 at 28 C. The reaction products were extracted in ethyl acetate containing 
0.1% sec-butyl-benzene as internal standard for GC/MS analysis. The retention times for the normal lactone,  abnormal 
lactone and unreacted (2R,5S)-(+)-dihydrocarvide are 17.42, 17.147 and 10.7, respectively. 
  
A 
B 
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Figure S10. GC/MS chromatograms of the reaction products of the CFE of WT CRE CHMOPhi1 in A) and its 
variant in B) with (+)-dihydrocarvone. Reaction conditions: CFE of WT CRE-CHMOPhi1 or its variant (50 L/mL), 
(+)-dihydrocarvone (5 mM) and 100 mM sodium phosphite in 500 mL 50 mM Tris, pH 7.0 at 28 C. The reaction 
products were extracted in ethyl acetate containing 0.1% sec-butyl-benzene as internal standard for GC/MS analysis. 
The retention times and mass fragmentation pattern for each compound are shown in the upper and lower panels of each 
part, respectively. The retention times for (2R,5R)-(+)-dihydrocarvone, (2R,5S)-(+)-dihydrocarvone,  abnormal lactone 
and normal lactone are 10.573, 10.845, 17.147 and 17.42, respectively. 
 
 
A 
B 
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1
H and 
13
C NMR Spectra of Lactone monomers  
 
 
 
Figure S11. 
1
H and 
13
C Spectra of menthide. NMR analyses were performed on a Bruker 400 MHz NMR 
spectrometer.  
Menthide, CDCl3, 400 MHz 
(4R,7S)-7-isopropyl-4-methyloxepan-2-one 
Menthide, CDCl3, 100 MHz 
(4R,7S)-7-isopropyl-4-methyloxepan-2-one 
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Figure S12. 
1
H and 
13
C Spectra of the abnormal lactone of (2R,5R)-(+)-dihydrocarvone. NMR analyses were 
performed on a Bruker 400 MHz NMR spectrometer. 
 
Abnormal lactone of (2R,5R)-(+)-dihydrocarvone, CDCl3, 100 MHz 
(3S,6R)-3-methyl-6-(prop-1-en-2-yl)oxepan-2-one 
 
Abnormal lactone of (2R,5R)-(+)-dihydrocarvone, CDCl3, 400 MHz 
(3S,6R)-3-methyl-6-(prop-1-en-2-yl)oxepan-2-one 
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Figure S13. 
1
H and 
13
C Spectra of the normal lactone of (2R,5R)-(+)-dihydrocarvone (dihydrocarvide). NMR 
analyses were performed on a Bruker 400 MHz NMR spectrometer. 
  
Normal lactone of (2R,5R)-(+)-dihydrocarvone (dihydrocarvide), CDCl3, 400 MHz 
 
Normal lactone of (2R,5R)-(+)-dihydrocarvone (dihydrocarvide), CDCl3, 100 MHz 
 
 
 
S16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S14. 
1
H and 
13
C Spectra of the lactone of  (+)-pulegone. NMR analyses were performed on a Bruker 400 
MHz NMR spectrometer.   
Lactone of (+)-pulegone, CDCl3, 100 MHz 
(R)-4-methyl-7-(propan-2-ylidene)oxepan-2-one 
 
 
Lactone of (+)-pulegone, CDCl3, 400 MHz 
(R)-4-methyl-7-(propan-2-ylidene)oxepan-2-one 
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Characterisation Data for the Lactone monomers 
 
(4R,7S)-7-isopropyl-4-methyloxepan-2-one [Menthide] 
Clear oil (402 mg) 
1
H NMR (400 MHz, CDCl3) 3.99-4.02 (1H, dd, J = 4, 4 Hz), 
2.40-2.54 (2H, m), 3.38-3.42 (1H, m), 1.77-1.93 (4H, m), 1.50-1.60 (1H, m), 1.20-
1.30 (1H, m), 1.00 (3H, d, J = 8 Hz), 0.91-0.94 (6H, t, J = 8 Hz) 
13
C NMR (100 
MHz, CDCl3) 175.00, 84.75, 42.61, 37.49, 33.37, 30.99, 30.46, 24.01, 18.44, 
17.14. 
 
(R)-4-methyl-7-(propan-2-ylidene)oxepan-2-one [lactone of (+)-Pulegone] 
Clear oil (121 mg) 
1
H NMR (400 MHz, CDCl3) 2.59-2.66 (1H, m), 2.34-2.43 (2H, 
m), 2.03-2.11 (1H, m), 1.90-1.98 (1H, m), 1.77-1.84 (1H, m), 1.67 (1H, s), 1.62 (1H, 
s), 1.26-1.35 (1H, s), 1.05 (3H, d, J = 4 Hz) 
13
C NMR (100 MHz, CDCl3) 173.31, 
143.58, 18.82, 41.00, 35.79, 29.80, 27.69, 22.32, 18.42, 17.37. 
 
(4R,7R)-7-methyl-4-(prop-1-en-2-yl)oxepan-2-one (Normal lactone of (2R,5R)-(+)-
dihydrocarvone= dihydrocarvide) 
Clear oil (211 mg) 
1
H NMR (400 MHz, CDCl3) 4.71 (1H, brs), 4.69 (1H, brs), 
4.40-4.47 (1H, m), 2.69 (1H, t, J = 12 Hz), 2.55-2.60 (1H, m), 2.25 (1H, t, J = 12 
Hz), 1.88-1.92 (2H, m), 1.69 (3H, s), 1.53-1.66 (2H, m), 1.32 (3H, d, J = 4 Hz) 
13
C NMR (100 MHz, CDCl3) 174.70, 148.49,  110.19, 76.70, 41.84, 40.24, 35.89, 
34.34, 22.66, 20.22. 
  
(3R,6S)-3-methyl-6-(prop-1-en-2-yl)oxepan-2-one (Abnormal lactone of (2R,5R)-(+)-
dihydrocarvone) 
Clear oil (190 mg) 
1
H NMR (400 MHz, CDCl3) 4.78 (1H, brs), 4.67 (1H, brs), 
4.12-4.14 (2H, m), 3.42 (3H, s), 2.69-2.77 (1H, m), 2.20-2.27 (1H, m), 1.72 (3H, 
brs), 1.51-1.69 (1H, m), 1.17 (3H, d, J = 8 Hz) 
13
C NMR (100 MHz, CDCl3) 
178.00, 145.69, 111.20, 71.66, 50.69, 46.49, 37.26, 34.19, 31.82, 21.84, 18.45. 
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Polymerization Methods 
 
Ring Opening Polymerization 
The composition of the polymerization reactions is described in Table S3.  
 
Table S3. Ring-opening polymerization (ROP) reaction setup. 
Monomer  [M]0 (mg) Catalyst 
(mg) 
Initiator 
(L) 
Toluene 
(mL) 
Polymer 
-Caprolactone  400 21.3 3.63 1.4 Polycarprolactone (PCL) 
Menthide  280.6 20 3.4 1.714 Polymenthide (PM) 
Dihydrocarvide  277.28 20 3.4 1.714 Polydihydrocarvide (PDC) 
[M]0 is the lactone monomer concentration of 1 M. both the catalyst[Mg(BHT)2(THF)2]0 and the initiator [BnOH]0 are 
at 0.02 M concentration. i.e. [M]0:[Mg(BHT)2(THF)2]₀:[BnOH]₀ is at a ratio of 50:1:1. The concentrations of the 
reactants are similar to the method reported previously.
3
  
 
Gel Permeation Chromatography (GPC) 
For GPC analysis, conventional measurements were performed using a Marlvern GPC (Viscotek 
GPC max model VE2001 GPC) with a Viscotek VE 3580 differential refractometer detector 
calibrated with polystyrene standards. Samples were dissolved in THF (1 mg/mL). The data were 
acquired and analysed on Viscotek OMNISEC software. The polymers were further characterised at 
Malvern Laboratories, UK using the OMNISEC system by advanced Mutli-Detection GPC from 
Malvern Instruments (Table 3 in the manuscript, Figure S17) . The GPC was coupled with 
refractive index (RI), Right-Angle Light Scattering (RALS), Low-Angle Light Scattering (LALS) 
and viscometer detection. Samples were prepared in THF (3 mg/mL). The three polymers were 
compared using the Mark-Houwink plot/equation (Equation 1). The temperature and solvent were 
fixed to investigate the relationship between the intrinsic viscosity []i and the molecular weight Mi 
of the fractionated polymer samples.  
 []i = KMi
a
      Equation 1 
 
  
 
 
Table S4.  Molecular weight and dispersitiesof the crude polymers obtained by conventional GPC analysis. 
Polymer Mn (kDa) Mw (kDa) ĐM 
Polymenthide (PM) 9.5 11.5 1.217 
Polydihydrocarvide (PDC) 6.8 8.4 1.235 
Polycaprolactone (PCL) 7.4 20.9 2.8 
Data were obtained by analysing the polymer samples in a Viscotek GPC max (model VE2001) with differential 
refractometer detector (Viscotek VE 3580) using narrow distribution polystyrene standards. Mn = number average 
molecular weight (kDa); Mw = weight average molecular weight (Da); Đ = sample dispersity (Mw/Mn). Samples were 
prepared in THF (1 mg/mL of solid polymer or 30 L of liquid polymer/mL), with fractions (200 L) separated on a set 
of standard ViscoGel columns. The columns and detectors were maintained at 35 C. 
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NMR Spectra of the Polymers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S15. 
1
H and 
13
C Spectra of polymenthide (PM). NMR analyses were performed on a Bruker 400 MHz NMR 
spectrometer. 
Polymenthide before purification 
Polymenthide after purification 
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Figure S16. 
1
H and 
13
C Spectra of polydihydrocarvide (PDC). NMR analyses were performed on a Bruker 400 MHz 
NMR spectrometer. 
 
  
Polydihydrocarvide before purification 
Polydihydrocarvide after purification 
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Polymer Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S17. Triple detection GP chromatograms of the produced polymers PM (in A), PDC (in B) and PCL (in 
C) using the OMISEC
TM
 triple detection method. The data were acquired and analysed by OMISEC
TM
 Multi-
Detection GPC system from Malvern Instruments. The GPC was coupled with refractive index (RI in black), Right-
Angle Light Scattering (RALS in green), Low-Angle Light Scattering (LALS in red) and viscometer detection 
(differential pressure, DP in blue). Samples were prepared in THF (3 mg/mL of solid polymer or 20 µl of liquid 
polymer/mL) and 50 µl injections of samples were separated isocratically on a set of standard ViscoGel columns. The 
columns and detectors were maintained at 35 C. The detectors recorded the elution of the samples from the columns 
and the analysis was performed using the OMNISEC
TM
 V10.20 software.   
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Figure S18. GP chromatograms for the polymer of the lactone of (+)-pulegone using the OMISECTM triple 
detection method. The data were acquired and analysed by the advanced OMISECTM Multi-Detection GPC system 
(Malvern Instruments). The GPC coupled with refractive index (RI in red), Right-Angle Light Scattering (RALS in 
green), Low-Angle Light Scattering (LALS in black) and viscometer detection (differential pressure, DP in blue). 
Samples were prepared in THF (3 mg/mL or 20 µl of liquid polymers/mL), 50 µl injections of samples were separated 
isocratically on a set of standard ViscoGel columns. The columns and detectors were maintained at 35 C. The detectors 
recorded the elution of the samples from the columns and the analysis was performed using the OMNISECTM V10.20 
software.  The analyte peak eluted very close to the permeation peak, at approximately 32 mL and the light scattering 
showed both positive and negative peaks 
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Figure S19. Mark-Houwink plot for the generated polymers PM (dotted line), PDC (dashed line) and PCL (solid 
line).  The plot was produced by plotting the Mw from the light scattering detector against the intrinsic viscosity on a 
log-log graph (Equation S1). Samples were prepared in THF (3 mg/mL for solid polymer or 20 µL of liquid 
polymer/mL) and 50 µL injections of samples were separated isocratically on a set of standard ViscoGel columns. The 
columns and detectors were maintained at 35 C. The detectors recorded the elution of the samples from the columns 
and the analysis was performed using the OMNISEC
TM
 V10.20 software. 
 
Similar ROP reactions were performed with the lactone of pulegone, with 
1
H NMR analysis 
showing a hint of polymer formation. However, GPC analysis did not show any evidence of 
polymer formations, with the potential analyte peak eluting very close to the permeation peak and 
light scattering showed both positive and negative peaks (Figure S24). This may be due to refractive 
index changes within the sample, due to low molecular weight compound presence (e.g. impurities).  
The lack of polymer formation with the lactone of pulegone may be due to steric hindrance of the 
orientation of the isobutene of the monomer. Further studies are required to determine suitable ROP 
conditions to enable polymers of pulegone lactone formation to be successful. 
 
Crystal Structure Discussion 
 
Sequence and Structural Holomogy 
Several structures of BVMO proteins were available in the protein data bank. The closest 
homologues to CHMOPhi1 are CHMO structures from Rhodococcus sp. HI-31
4-6
, phenylacetone 
monooxygenase (PAMO) from Thermobifida fusca
7, 8
, OTEMO from Pseudomonas putida
9
, steroid 
monooxygenase (STMO) from Rhodococcus rhodochrous
10
 and more recently BVMOAFL838 from 
Aspergillus flavus
11
 and CHMO structures from the thermophile Thermocrispum municipall.
12
 
Analysis using the DALI server
13
 identified CHMO structures from Rhodococcus sp. HI-31, namely 
CHMOopen (PDB 3GWF), CHMOclosed (PDB 3GWD), CHMOrotated in complex with cyclohexanone 
(PDB 3UCL), and CHMOTight (PDB 4RG3) and CHMOLoose (PDB 4RG4) in complex with -
caprolactone, have the highest similarity with CHMOPhi1, with RMSD values ranging from 0.6-0.9 
Å. CHMOPhi1 and CHMO from Rhodococcus sp. HI-31 share a very high sequence identity of 90%.  
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Computational Methodologies 
Molecular Dynamics Simulations 
The crystal structures for the CHMOPhi1 (WT and its variant) reported here have been used as 
starting coordinates for MD simulations. Six sets of different MD simulations were performed: WT 
and variant including the NADPH and FAD cofactor and no substrate (2 sets of MD simulations), 
plus WT and variant plus Criegee intermediate in eq, eq or ax, ax conformation at the starting 
geometry (4 sets of MD simulations). Missing residues (496-504) on the mutant were modelled 
based on the WT geometry.  
The Criegee intermediate was built from the crystal structure coordinates of the FAD cofactor, the 
axial or equatorial conformations refers to the (2R,5R)-(+)-dihydrocarvone moiety of the molecule. 
Ad hoc parameters were produced for the (2R,5R)-(+)-dihydrocarvone substrate and Criegee 
intermediates using the CHARMM General Force Field program (CGenFF)
14, 15
 via the ParamChem 
service. As CGenFF produces only a quick by-analogy parametrization we have no reason to expect 
good parameters for the Criegee intermediate, especially for the peroxide bridge moiety. For this 
reason, a dihedral restraint of 180° for the O-O-C-N dihedral (where the oxygen atoms correspond 
to the peroxide bridge and the N to the FAD moiety) was imposed based on the results of the DFT 
calculations, see below. Additionally, four distance restraints of 2 Å for the Criegee intermediate 
simulations were imposed (Scheme S1). These restraints were based on the distances reported in 
earlier work by  Polyak et. al.
16
 Please notice the distances reported by Polyak et. al involve H 
atoms and the distances used by us involve the corresponding H-bonded heavy atom. Thus, the 
distance CYHN:O1-Arg329:H (Polyak et al.’s nomenclature) = 1.60 Å becomes larger when we 
use the distance CYHN:O1-Arg329:N. As the N - H bond distance is approximately 1 Å but the 
angle CYHN:O1-Arg329:H-Arg329:N is not necessarily 180o, the distance CYHN:O1-
Arg329:N can range from approximately 1.60 Å to 2.60 Å, depending on the angle adopted. We 
have restrained the CYHN:O1-Arg329:N distance to a medium 2.0 Å distance; the same applies to 
the other distance restraints used. The simulations were set up using standard simulation protocols 
with the CHARMM-GUI.
17, 18
 Hydrogen coordinates were generated using standard protonation 
states for all ionizable residues using CHARMM.
19
 The system was solvated with a pre-equilibrated 
TIP3P truncated octahedral water box. Water molecules were randomly replaced by ions to ensure 
the neutralization of the system, and an additional KCl salt concentration corresponding to 0.15 M. 
We ran production trajectories of 100 ns after 10 ns of equilibration using NAMD, and for each MD 
starting configuration, we performed three replicas.
20
 Temperature and pressure were held constant 
at 300 K and 1 atm, respectively. We used the CHARMM36
21
 force field with periodic boundary 
conditions and the particle mesh Ewald method
22
 for the long-range electrostatics in combination 
with a 12 Å cutoff for the evaluation of the nonbonded interactions. 
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Scheme S1. Distance restraints (dashed lines) used during MD simulations of Criegee intermediate. All distance 
restraints were set to 2Å. Notice that the distances are between heavy (non-hydrogen) atoms. 
 
DFT Cluster Models 
All geometry optimizations used Jaguar (v. 8.5),
23
  and the Zhao and Truhlar modified mPW91 + 
modified B95 (PWB6K) functional.
24
  This functional was used in small-molecule studies of the 
Baeyer-Villiger rearrangement,
25, 26
 where it performed well. Single point energies of the enzyme 
active site (M(med), see below for discussion of active site models used) have also been calculated 
with the standard B3LYP functional
27-33
 as implemented in Jaguar, as well as the dispersion-
corrected version (D3
34, 35
) of this functional (B3LYP-D3). In addition, loose convergence criteria 
(5 times larger than default criteria) were used in the enzyme active site models. Test calculations 
on other complexes using the more stringent default convergence criteria did not lead to significant 
changes in energies, bond lengths, or angles, but were much more time-consuming.   
All calculations relating to the protein environment used the double zeta quality 6-31+G* basis set 
to save on computational cost. For the active site model of BVMO, energies including CDM solvent 
effects were determined from single point calculations on these geometries, incorporating the 
Poisson–Boltzmann finite-element model of solvation36, 37 as implemented in Jaguar. The dielectric 
constant was set to 4, as commonly used in the cluster model approach
38
 and the probe radius to 2 Å 
(labelled as CDM_protein).  
 
 
Figure S20. Cluster model (M(med_W) set-up. The carbon atoms constrained to crystallographically-observed 
positions are shown as purple spheres (2 in FADHOO
-
, 2 in NADP
+
 & ribose, 1 in R330, 1 in W493).  
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We have considered an active site model including substrates, NADP
+
 and FADHOO
-
 versions of 
the cofactors, as well as the side chain of an arginine residue R330 (R329 in Polyak’s work), with a 
protonated guanidium, which, together with the NADP
+
 ribose hydroxyl groups, contributes to the 
hydrogen-bonding with the substrates (labelled M(med), 5 Cartesian constraints of residues to 
crystallographically observed positions). As discussed in the manuscript, this model was extended 
by inclusion of a tryptophan residue W493 (M(med_W), 6 constraints, Figure S20) and simplified 
by omission of the R330 residue (M(med_noR), 4 constraints). In addition, a cut-down version of 
the active site including only the FADHOO
-
 cofactor (labelled M(sml), 2 constraints, -1 charge) was 
explored. The overall charge of these active site models is +1 for all apart from M(sml) where it 
is -1. The discussion below will also consider our attempts at optimising an extended model of the 
active site, including the residues identified for mutation (phenylalanines F249, F280, F435), as 
well as the conserved tryptophan (W493), threonine (T436) and leucine (L438) (labelled 
M(extWT), 11 constraints), and the corresponding variant (phenylalanines to alanines, F249A, 
F280A, F435A) (labelled M(extMU), 11 constraints).  
Unfortunately, we were unable to complete frequency calculations on the DFT models discussed 
here; structural similarity and the eigenvectors followed during optimizations strongly suggest that 
these geometries are the correct transition states. Unless otherwise stated, vibrational frequencies 
were not computed for other stationary points, and so the energetic data do not include a correction 
for zero-point energy, although we note that this would be expected to be quite small.  
The calculations reported here focussed on the active site, rather than the wider protein 
environment, and we used a small number of constraints to hold residues in the 
crystallographically-observed positions. This “cluster” approach has been used for the exploration 
of selectivity in enzyme catalysis with success (see, for example, reference 
39
), not in the least 
because, as long as the key properties of the active site are captured, all isomers considered are 
affected similarly by the constraints,  leading to some helpful cancellation of errors. The effect of 
the wider protein environment can be introduced by using a continuum dielectric model of solvation 
as described above, the impact on calculated relative energies was relatively small in the present 
case. 
To position the (2R,5R)-(+)-dihydrocarvone substrate in the cluster model (M(med)) for the 
reactant, Criegee intermediate and product geometry, we started with distance constraints as 
reported by Polyak and co-workers for QM/MM optimizations;
16
 once these constrained 
optimizations had converged, the constraints were removed and the structures re-optimised. Other 
optimizations started from these geometries, with addition/removal of residues as appropriate. Some 
structural adjustments were used, due to the different steric properties of the (2R,5R)-(+)-
dihydrocarvone substrate compared to the cyclohexanones considered by Polyak et al.,
16
 however, 
these were relatively minor, as shown by the structural data summarised below. 
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Computational Results and Discussion 
 
Active Site Models 
 
Figure S21. Superposition of CHMOrho structure used in Polyak’s QM/MM calculations
16
 3GWD
40
 (green) and 
CHMOPhi1 reported in this work (pink). A) FAD, NADPH cofactors, W493, R330 as well as the mutated 
phenilananines residues (249, 280, 435). b) superposition of residues used in DFT cluster calculations. Notice the 
geometries of both reported PDB entries are very similar. 
 
Enzyme active site models were generated from the same structure determined by X-ray 
crystallography described by Polyak and co-workers
16
 (CHMOrho, Rhodococcus sp., strain HI-31, 
PDB code 3GWD).
40
 An overlay of the active site with the structure of CHMOPhi1 was shown to be 
very similar (Figure S21).  
MD Simulation Results 
 
Figure S22. Superposition of MD simulation snapshots collected at uniform intervals showing the WT (blue), 
variant (red) CHMOPhi1. a) Zoomed control loop (residues 489 to 506). b) RMSD during the MD simulations of 
control loop residues. 
F435
F249
F280
R330
FAD
NADPH
a) b)
R330
FAD
NADPH
W493
W493
R489	G490	D491	S492	W493	I494	F495	G496	A497	N498	V499	S505	V506
a)
b)
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The MD simulations of the enzyme without substrate (Figure S22) show segments 486 to 506 are 
more disordered in the  variant (RMSD of each amino acid in Figure S22b). A disordered control 
loop is characteristic of an open conformation which is consistent with the experimental 
crystallographic data. Figure S23 shows a superposition of the frames along the MD simulations of 
the protein with the Criegee intermediate. In the case of the WT, the eq, eq conformation is stable 
during the whole MD simulation (Figure S23a) while the ax, ax conformation changes to eq, eq 
after 40 ns (Figure S23b; this inversion was observed after 16 ns and after 21 ns in replicas 2 and 3 
respectively). This change is mainly due to the strong steric interaction with W493 that is very close 
to the substrates putative position in the WT. In the case of the variant, both eq, eq and ax, ax 
conformation can be accommodated in the binding pocket during the whole MD (Figure S23c,d). 
This is because the active site in the variant is considerably larger and so able to better 
accommodate the ax, ax conformation. Additionally the control loop is more flexible and the W493 
moves away to a different position.   
 
Figure S23. Superposition of MD simulation snapshots collected at uniform intervals showing part of the Criegee 
intermediate and NADP
+
, residues 249, 280, R330, 435 and W493 in CHMOPhi1. A) WT with Criegee intermediate 
in eq, eq conformation; B)  WT with Criegee intermediate in ax, ax conformation; C) variant with Criegee intermediate 
in eq, eq conformation and D) variantwith Criegee intermediate in ax, ax conformation.  
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DFT Calculations 
 
Cyclohexanone Monooxgenase (CHMO) Catalysis 
For our initial studies of the enzyme-catalysed Baeyer-Villiger oxidation, we based our calculations 
on the active site model as shown in the MD, QM/MM and QM studies reported by Polyak and co-
workers.
16, 41
 This model (M(med)) includes the relevant co-factors, including the ribose side-chain 
of NADP
+
, as well as an arginine residue adjacent to the site found to hydrogen bond with the 
substrate (denoted R330 here, but R329 in Polyak et al’s work). Both the dihydrocarvone substrate 
(2R,5R isomer) and a 2-methyl-substituted cyclohexanone were introduced to the active site and 
reactant, Criegee intermediate, migration transition state and product complexes were optimised 
with five cluster model constraints as described above, at the PWB6K/6-31+G* level of theory. The 
relevant equatorial and axial conformers of the substrates were considered and Table S5 shows the 
calculated potential energies. 
 
 
The energy differences between conformers are much better defined for the (2R,5R)-(+)-
dihydrocarvone substrate than for 2-methyl-cyclohexanone. Note that interactions between the 
substrate and the active site are stronger in the Criegee intermediate than for the reactant, such that 
the calculated energy differences between conformers are less reliable/more noisy in the reactant. 
The eq, eq conformer shows short contacts between the substrate and the ribose attached to the 
NADP
+
 co-factor, which destabilise the Criegee intermediate. These results suggest that the overall 
barrier to reaction is lower for the axial conformer, leading to the normal lactone product. In 
addition, the active site shows a preference for the normal lactone product in both conformers, 
although again this may be prone to conformational noise as interactions are weaker than for the 
Criegee intermediate and transition state.  
Table S5. Relative potential energies for conformers of (2R)-methyl-cyclohexanone and (2R,5R)-(+)-
dihydrocarvone (M(med), PWB6K/6-31+G*, kcal mol
-1
). 
 
 (2R)-Me, eq (2R)-Me, ax (2R,5R)-(+)-
dihydrocarvone, 
eq, eq 
(2R,5R)-(+)- 
dihydrocarvone,  
ax, ax 
Reactant 0.0 1.1 0.0 8.5 
Criegee 
Intermediate 
7.2 2.1 8.0 9.1 
Transition 
State
a
 
25.8 (AL) 24.4 (NL) 25.9 (AL) 28.4 (NL) 
Product  -68.2 (AL), -
68.9 (NL) 
-65.5 (NL), -
62.4 (AL) 
-67.3 (AL), -69.2 
(NL) 
-64.0 (NL) , -60.1 (AL) 
a
Only one TS could be located for each conformer.   
 
O
eq, eq
O
ax, ax
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For the (2R,5R)-(+)-dihydrocarvone substrate, reactant, Criegee intermediate and transition state 
energies favour the eq, eq conformer which leads to the abnormal lactone product. For the ax, ax 
conformer, reactant and Criegee intermediate are again close in energy, while the selectivity here 
favours the normal lactone. For all product complexes, the normal lactone is energetically favoured 
in this model.  
For the (2R,5R)-(+)-dihydrocarvone in M(med), method effects were also explored, considering 
dispersion, free energy and solvation corrections to model the protein environment, as well as 
exploring the effect of different density functionals. These results are summarised in Table S6. We 
note that the PWB6K functional was optimised to capture thermochemistry, thermochemical 
kinetics and nonbonded interactions
24
 reasonably well, which should include dispersion effects to 
some extent.  
 
 
While changes to the computational approach affect the calculated barriers, especially when 
dispersion corrections are used with the B3LYP functional, they do not substantially alter the 
predicted selectivities in this case. The active site reactant model is consistently favouring the eq, eq 
conformer, and once the substrate is in the active site, the Criegee intermediate also favours the eq, 
eq conformer whereas the migration barrier is lower for the ax, ax conformer. Both product 
geometries can be accommodated in the active site, but only transition states leading to the 
experimentally observed lactone product could be located.  
Barriers to this reaction are lower for the dispersion-corrected B3LYP-D3 functional, and these are 
also in better agreement with the QM/MM data reported by Polyak and co-workers
16
 for the 
cyclohexanone substrate. While dispersion corrections have been found unlikely to affect relative 
energies significantly in Polyak et al.’s work,16 here they seem to improve on results obtained with 
other functionals, even though the PWB6K functional is designed to capture nonbonded interactions 
well. Note, however, that the attractive interactions within the active sites modelled could perhaps 
also be exaggerated in cluster models such as this when a dispersion correction is included, as the 
“balancing interactions” with the wider protein and solvent environment are not likely to be fully 
captured by thecontinuum model of solvation, so the two sets of optimizations with different 
Table S6. Method effects on calculated energies (kcal moL
-1
) for M(med) cluster model. 
 PWB6K E 
(opt) 
PWB6K E, sl 
(eps=4) (SP
a
) 
B3LYP E 
(SP
a
) 
B3LYP-D3 E 
(SP
a
) 
B3lYP-D3 E 
(opt) 
eq, eq      
Reactant 0.0 0.0 0.0 0.0 0.0 
Criegee IM 8.0 5.5 18.2 9.5 9.6 
Transition State
b
 25.9 24.2 23.5 14.5 15.5 
Reactant -67.3 (AL), -
69.2 (NL) 
-67.1 (AL), -
66.2 (NL) 
-65.4 (AL), -
65.5 (NL) 
-62.7 (AL), -61.6 
(NL) 
-61.5 (AL), -63.4 
(NL) 
ax, ax      
Reactant 8.5 8.4 10.5 7.9 7.8 
Criegee IM 9.1 8.8 20.3 10.8 11.1 
Transition State
a
 28.4 (19.9)
c
 27.7 (19.3)
 c
 25.6 (15.1)
 c
 18.8 (10.9)
 c
 18.6 (10.8)
c
 
Reactant -64.0 (NL) , 
-60.9 (AL) 
-63.0 (NL), -
61.4 (AL) 
-60.9 (NL), -
58.4 (AL) 
-60.0 (NL), -57.3 
(AL) 
-58.8 (NL), -56.0 
(AL) 
a
Using PWB6K optimised geometry. 
b
Only one TS could be located for each conformer. 
c
 Barrier relative to ax, ax 
reactant. 
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functionals may provide a guide to the likely range of values. Most importantly, our interpretation 
looks to be robust to changes in the DFT approach used. 
Residue W493 is important for interactions between the substrate and the residues in the active site, 
and has thus been included in M(med_W), with M(med) a possible model for the variant where this 
residue moves away from the reacting site. A number of different changes can be observed in the 
crystal structure geometry and MD simulations for the variant and we have explored some of these 
by modifying the cluster models in DFT calculations. Thus, the increased conformational freedom 
of R330 might lead it to move away from the reacting site, this has been probed with M(med_noR), 
which does not include W493 or R330. The NADP
+
 co-factor might also become more mobile, with 
M(sml) considering interaction with only the FADHOO
-
 moiety. Table S7 compares the calculated 
potential energies for these variations with the data for M(med). 
 
 
Table S7. Relative potential energies for conformers of (2R,5R)-(+)-dihydrocarvone, PWB6K/6-31+G*, kcal 
moL
-1
 
 M(sml) M(med_noR) M(med) M(med_W) 
eq, eq     
Reactant 0.0 0.0 0.0 0.0 
Criegee IM 8.4 -1.2 8.0 6.8 
Migration TS
a 
(AL) 26.7 19.3 25.9 25.6 
Product (AL) -62.7 -69.8 -67.3 -66.7 
ax, ax     
Reactant 5.0 1.9
b
 8.5 3.5 
Criegee IM 10.2 0.9 9.1 11.6 
Migration TS
a
 (NL) 29.5 (24.5)
c
 24.4 (22.5)
c
 28.4 (19.9)
c
 35.3 (31.8)
c
 
Product (NL) -72.7 -67.7 -64.0 -61.7 
a
Only one TS could be located for each conformer.
 b
Change in O2 orientation due to loss of H-bonding. 
c
Barrier 
relative to ax, ax reactant. 
 
Comparison of M(med) and M(med_W) showed interactions with the tryptophan residue probably 
destabilise the eq, eq conformer somewhat, reducing the energy difference between the two 
conformers in the reactant complexes. For these cluster models, substrate and product lactone are 
held quite loosely by a range of hydrogen bonds in the protein active site, making these energies 
more prone to be affected by computational noise, slight differences in starting geometries and the 
consideration of additional residues (see below) than the Criegee intermediates and migration 
transition states. This could affect M(sml) and M(med_noR) energetics here and Table S8 
summarises the barriers to reaction from each Criegee intermediate to the migration transition state. 
Tables S9-S14 and Figure S24 show the values for the structural parameters. 
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Table S8. Barriers to reaction from Criegee intermediates as indicated for conformers of (2R,5R)-(+)-
dihydrocarvone, PWB6K/6-31+G*, kcal mol
-1
. 
 M(sml) M(med_noR) M(med) M(med_W) 
eq, eq 18.3 20.5 17.9 18.8 
ax, ax 19.3 23.5 19.3 23.7 
 
These results suggest that FADHOO
-
 alone is catalytically competent once a Criegee intermediate 
has been formed; there may be other factors such as substrate interactions with the active site which 
are compromised by these simplifications, but the barriers to reaction are relatively consistent, if a 
bit high with the DFT approach used here. There are some differences between the reactivity of the 
two conformers, but these are small and may stretch the reliability of both the cluster approach and 
the computational methodology and software used here. In addition, structural analysis of M(sml) 
for the ax, ax conformers shows substrate rotation into an area normally occupied by the NADP
+
 
co-factor, while for M(med_noR), some movement into the site of the arginine residue occurs. 
These changes suggest that more extensive sampling to fully understand the dynamic behaviour of 
the active site in variant and WT are necessary before such energy differences can be considered 
reliable; this lies outside of the scope of the present study. 
 
 
Figure S24. Modelled structure, indicating atom numbering for Tables S9- S14. 
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Table S9. Key structural parameters from calculated geometries for PWB6K with substrate (2R,5R)-(+)-
dihydrocarvone . A) M(med_W) 
Interaction Reactant Criegee IM TS Product  
eq, eq   (AL) (AL) 
rel. E (kcal mol
-1
) 0.0 6.8 25.6 -66.7 
FAD_C – FAD_O1 1.411 1.438 1.384 1.363 
FAD_O1 – FAD_O2 1.429 1.426 1.837 4.726 
FAD_O2 – Cyh_C 2.919 1.514 1.341 1.316 
Cyh_C – Cyh_O 1.217 1.326 1.299 1.217 
NAD_NH – FAD_O1 1.975 2.604 2.362 1.925 
Arg_NH1 – Cyh_O 3.167 1.800 1.823 2.061 
Arg_NH2 – FAD_O2 1.593 1.879 1.935 4.128 
Rib_OH1 – Cyh_O 1.820 1.824 1.898 1.986 
Rib_OH2 – Cyh_O 2.527 1.702 1.668 2.468 
Rib_OH2 – Arg_NH1 2.227 2.005 2.149 2.616 
shortest contact with 
W493 
3.524 (NH-MeH) 2.482 (CH-CyhH) 2.678 (CH-MeH) 3.638 (CH-MeH) 
ax, ax   (NL) (NL) 
rel. E (kcal mol
-1
) 3.5 11.6 35.3 -61.7 
FAD_C – FAD_O1 1.402 1.435 1.376 1.361 
FAD_O1 – FAD_O2 1.434 1.425 1.826 5.113 
FAD_O2 – Cyh_C 3.212 1.522 1.337 1.314 
Cyh_C – Cyh_O 1.219 1.325 1.290 1.218 
NAD_NH – FAD_O1 2.194 2.474 2.266 1.843 
Arg_NH1 – Cyh_O 3.152 1.767 1.726 1.846 
Arg_NH2 – FAD_O2 1.566 2.450 1.860 3.008 
Rib_OH1 – Cyh_O 1.757 1.936 2.582 2.678 
Rib_OH2 – Cyh_O 2.596 1.589 1.704 2.212 
Rib_OH2 – Arg_NH1 2.232 2.057 2.216 2.641 
shortest contact with 
W493 
2.409 (CH-
propMeH) 
2.238 (CH-
propMeH) 
2.294 (CH-
propMeH) 
2.223 (NH_propCH) 
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Table S10.  Key structural parameters from calculated geometries for PWB6K with substrate (2R,5R)-(+)-
dihydrocarvone. B) M(med) 
Interaction Reactant Criegee IM TS Product (NL) Product (AL) 
eq, eq   (AL) (NL) (AL) 
rel. E (kcal mol
-1
) 0.0 8.0 25.9 -69.2 -67.3 
FAD_C – FAD_O1 1.406 1.436 1.379 1.357 1.360 
FAD_O1 – FAD_O2 1.433 1.426 1.866 4.551 4.223 
FAD_O2 – Cyh_C 2.940 1.510 1.333 1.316 1.318 
Cyh_C – Cyh_O 1.216 1.326 1.295 1.217 1.216 
NAD_NH – FAD_O1 2.003 2.425 2.303 1.847 1.857 
Arg_NH1 – Cyh_O 2.918 1.789 1.823 1.918 2.400 
Arg_NH2 – FAD_O2 1.555 1.971 1.939 4.936 3.516 
Rib_OH1 – Cyh_O 1.827 1.876 1.902 2.528 1.894 
Rib_OH2 – Cyh_O 2.215 1.641 1.672 1.960 1.980 
Rib_OH2 – Arg_NH1 2.287 2.155 2.779 2.477 2.560 
ax, ax   (NL) (NL) (AL) 
rel. E (kcal mol
-1
) 8.5 9.1 28.4 -64.0 -60.1 
FAD_C – FAD_O1 1.401 1.432 1.380 1.360 1.358 
FAD_O1 – FAD_O2 1.433 1.426 1.811 5.188 4.054 
FAD_O2 – Cyh_C 2.820 1.518 1.339 1.315 1.301 
Cyh_C – Cyh_O 1.220 1.323 1.299 1.217 1.223 
NAD_NH – FAD_O1 1.944 2.352 2.209 1.810 1.850 
Arg_NH1 – Cyh_O 2.108 1.719 1.715 1.843 1.957 
Arg_NH2 – FAD_O2 1.500 1.891 1.892 4.443 4.351 
Rib_OH1 – Cyh_O 2.294 2.116 2.232 3.037 2.224 
Rib_OH2 – Cyh_O 1.789 1.591 1.620 2.076 1.932 
Rib_OH2 – Arg_NH1 2.448 2.128 2.120 2.618 2.353 
Table S11. Key structural parameters from calculated geometries for PWB6K with substrate (2R,5R)-(+)-
dihydrocarvone. C) M(med_noR) 
Interaction Reactant Criegee IM TS Product 
eq, eq   (AL) (AL) 
rel. E (kcal mol
-1
) 0.0 -1.2 19.3 -69.8 
FAD_C – FAD_O1 1.398 1.421 1.371 1.360 
FAD_O1 – FAD_O2 1.439 1.422 1.823 4.223 
FAD_O2 – Cyh_C 2.847 1.520 1.339 1.318 
Cyh_C – Cyh_O 1.214 1.316 1.287 1.216 
NAD_NH – FAD_O1 2.167 2.237 2.470 1.857 
Rib_OH1 – Cyh_O 1.773 1.761 1.679 1.894 
Rib_OH2 – Cyh_O 2.765 1.618 1.614 1.980 
Rib_OH2 – FAD_O2 1.642 3.592 3.203 3.662 
ax, ax   (NL) (NL) 
rel. E (kcal mol
-1
) 1.9 0.9 24.4 -67.7 
FAD_C – FAD_O1 1.395 1.419 1.371 1.360 
FAD_O1 – FAD_O2 1.438 1.416 1.807 5.188 
FAD_O2 – Cyh_C 3.263a 1.511 1.341 1.315 
Cyh_C – Cyh_O 1.221 1.320 1.286 1.217 
NAD_NH – FAD_O1 1.758 2.168 2.283 1.810 
Rib_OH1 – Cyh_O 1.849 1.848 1.817 3.037 
Rib_OH2 – Cyh_O 1.836 1.565 1.585 2.076 
Rib_OH2 – FAD_O2 3.187 3.198 3.020 4.186 
a
O2 rotation away from substrate. 
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Table S12. Key structural parameters from calculated geometries for PWB6K with substrate (2R,5R)-(+)-
dihydrocarvone. D) M(sml) 
Interaction Reactant Criegee IM TS Product 
eq, eq   (AL) (AL) 
rel. E (kcal mol
-1
) 0.0 8.4 26.7 -62.7 
FAD_C – FAD_O1 1.366 1.388 1.351 1.317 
FAD_O1 – FAD_O2 1.447 1.429 1.804 3.971 
FAD_O2 – Cyh_C 3.725a 1.652 1.372 1.336 
Cyh_C – Cyh_O 1.212 1.257 1.253 1.201 
ax, ax   (NL) (NL) 
rel. E (kcal mol
-1
) 5.0 10.2 29.5 -72.7 
FAD_C – FAD_O1 1.368 1.387 1.350 1.318 
FAD_O1 – FAD_O2 1.446 1.421 1.785 4.621 
FAD_O2 – Cyh_C 4.017a 1.621 1.362 1.430 
Cyh_C – Cyh_O 1.212 1.265 1.244 1.205 
a
 Substrate has moved “above” O2. 
Table S13. Key structural parameters from calculated geometries for B3LYP-D3 with substrate (2R,5R)-(+)-
dihydrocarvone.  
Interaction Reactant Criegee IM TS Product (NL) Product (AL) 
eq, eq   (AL) (NL) (AL) 
rel. E (kcal mol
-1
) 0.0 9.6 15.5 -63.4 -61.5 
FAD_C – FAD_O1 1.440 1.468 1.411 1.377 1.382 
FAD_O1 – FAD_O2 1.466 1.476 1.846 4.441 4.120 
FAD_O2 – Cyh_C 2.906 1.551 1.371 1.333 1.337 
Cyh_C – Cyh_O 1.233 1.338 1.325 1.233 1.230 
NAD_NH – FAD_O1 1.951 2.429 2.349 1.828 1.846 
Arg_NH1 – Cyh_O 3.147 1.729 1.777 1.859 2.447 
Arg_NH2 – FAD_O2 1.577 1.866 1.833 4.841 3.459 
Rib_OH1 – Cyh_O 1.776 1.867 1.892 2.526 1.869 
Rib_OH2 – Cyh_O 2.493 1.625 1.625 1.905 1.939 
Rib_OH2 – Arg_NH1 2.226 2.080 2.135 2.449 2.588 
ax, ax   (NL) (NL) (AL) 
rel. E (kcal mol
-1
) 7.8 11.1 18.6 -58.8 -56.0 
FAD_C – FAD_O1 1.434 1.465 1.406 1.378 1.376 
FAD_O1 – FAD_O2 1.467 1.472 1.843 5.075 3.987 
FAD_O2 – Cyh_C 2.827 1.561 1.361 1.333 1.319 
Cyh_C – Cyh_O 1.239 1.335 1.318 1.231 1.239 
NAD_NH – FAD_O1 1.996 2.302 2.178 1.799 1.842 
Arg_NH1 – Cyh_O 2.380 1.695 1.771 1.787 1.907 
Arg_NH2 – FAD_O2 1.421 1.815 1.769 4.327 4.276 
Rib_OH1 – Cyh_O 1.960 2.134 2.202 3.249 2.191 
Rib_OH2 – Cyh_O 1.807 1.570 1.632 2.030 1.911 
Rib_OH2 – Arg_NH1 2.397 2.094 2.115 2.589 2.346 
 
 
S36 
These data suggest that different versions of the DFT cluster model used are quite well-defined and 
able to retain a range of short contacts with the substrate/product molecules throughout all steps, 
supporting the catalysis. The two substrate conformers lead to slight differences in their interactions 
with the residues modelled, likely dominated by the steric bulk of the propenyl substituent for the 
dihydrocarvone. These are best illustrated by inspection of Figure S20 which illustrates differences 
between the key species for M(med).  
 
Figure S25. Comparison of conformers in active site region. 
Table S14.  Key structural parameters from calculated geometries for PWB6K with substrate 2-methyl-
cyclohexanone.  
Interaction Reactant Criegee IM TS Product (NL) Product (AL) 
eq   (AL) (NL) (AL) 
rel. E (kcal mol
-1
) 0.0 7.2 25.8 -68.9 -68.2 
FAD_C – FAD_O1 1.409 1.436 1.379 1.358 1.361 
FAD_O1 – FAD_O2 1.432 1.425 1.869 4.580 4.290 
FAD_O2 – Cyh_C 2.932 1.508 1.331 1.314 1.316 
Cyh_C – Cyh_O 1.218 1.330 1.291 1.217 1.218 
NAD_NH – FAD_O1 2.008 2.512 2.321 1.867 1.881 
Arg_NH1 – Cyh_O 2.916 1.713 1.831 1.892 2.141 
Arg_NH2 – FAD_O2 1.589 1.900 1.935 1.714 1.761 
Rib_OH1 – Cyh_O 1.833 1.853 1.902 2.456 1.992 
Rib_OH2 – Cyh_O 2.476 1.660 1.674 1.983 2.099 
Rib_OH2 – Arg_NH1 2.249 2.023 2.161 2.446 2.492 
ax   (NL) (NL) (AL) 
rel. E (kcal mol
-1
) 1.1 2.1 24.4 -65.5 -62.4 
FAD_C – FAD_O1 1.408 1.435 1.381 1.359 1.356 
FAD_O1 – FAD_O2 1.431 1.425 1.813 4.974 4.647 
FAD_O2 – Cyh_C 3.357 1.495 1.336 1.311 1.317 
Cyh_C – Cyh_O 1.220 1.332 1.302 1.221 1.216 
NAD_NH – FAD_O1 1.983 2.423 2.214 1.907 1.860 
Arg_NH1 – Cyh_O 3.570 1.677 1.725 1.958 1.956 
Arg_NH2 – FAD_O2 1.571 1.877 1.885 4.383 4.955 
Rib_OH1 – Cyh_O 1.768 1.924 2.030 1.980 2.476 
Rib_OH2 – Cyh_O 2.797 1.580 1.623 2.239 2.031 
Rib_OH2 – Arg_NH1 2.256 2.100 1.381 1.359 1.356 
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Transition states were initially located for a cut-down model (M(sml) containing only the 
FADHOO
-
 cofactor and not the NADP
+
 or the relevant arginine residue. Despite these 
simplifications, transition states could not be found for the less-favourable product in either case; 
some transition states involved rotation of the substrate relative to the co-factor’s plane, which 
could not be accommodated in the active site due to close contacts with other residues present and 
perhaps suggest that selectivity arises because this site is well-defined. For both Criegee 
intermediate and transition state, the eq, eq conformer is favoured due to fewer short contacts 
between the methyl substituent and the cofactor, twisting the substrate away from favourable 
alignment for the migration step.  
The structural analysis of WT and variant CHMOPhi1 suggested that additional residues “behind” 
the active site play an important role in determining the experimentally observed selectivity, as 
discussed in the manuscript. We experimented with calculations on such an extended cluster model, 
initially including the W493 in both WT and variant, as well as the mutated residues and additional 
residues from the control loop. This gave a model containing 240 atoms (2384 basis functions) for 
the WT (M(extWT) and 210 atoms (2036 basis functions) for the variant (M(extMU)), with 11 
constraints used in each case. At this stage of our study, we did not have a full variant crystal 
structure geometry, so used the tryptophan position as observed in the WT for W493.  
Optimizations of these extended models proved possible for both reactants and Criegee 
intermediates, but were found to be very sensitive to starting geometry and the constraints used, as 
well as very slow to converge. In the WT, the phenylalanine residues were the likely source of this 
sensitivity, while the interactions between ax, ax substrate and some of the mutated residues 
appeared important for the variant model. While these calculations showed a switch in energy 
preference for the Criegee intermediates, in line with experimental observations, the reactant 
optimizations appeared less consistent, giving quite variable energies and structures in response to 
minor changes in the starting geometries. In view of the MD simulation results reported here, which 
also suggest considerable flexibility in this region, we judged our current static cluster models too 
unreliable for selectivity predictions and have thus not attempted transition state optimizations to 
evaluate the overall reaction barriers. A more complete exploration of selectivity, combining MD 
sampling and QM/MM calculations from multiple starting configurations, lies beyond the scope of 
this study. 
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